INT — Intellego Technologies AB Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Intellego Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | PRESS | PRESS |
| Standards: | SAS | — | SAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9.15 | 57.8 | 186 | 94 | 98 |
| Cost of Revenue | |||||
| Gross Profit | 1.95 | 13.5 | 128 | 33.5 | -116 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 14.1 | 69.2 | 103 | 109 | 273 |
| Operating Profit | -4.96 | -11.4 | 83.1 | -15.2 | -175 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.03 | -16.8 | 68.8 | 1.97 | -187 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.96 | -15.1 | 59.6 | -0.268 | -189 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.96 | -15.1 | 59.6 | -0.268 | -189 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.96 | -15.1 | 59.6 | -0.269 | -189 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.202 | -0.679 | 2.31 | -0.01 | -6.16 |
| Dividends per Share |